KAIST researchers have developed a method that attaches DNA fragments to mRNA to slow the onset of protein production, ...

All cells need to sense and respond to their environment, to know when to activate genes, build proteins, and carry out their ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

All cells need to sense and respond to their environment, to know when to activate genes, build proteins, and carry out their ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the blueprint for functional ...

RNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the ...

While mRNA vaccines trigger potent initial immune responses, emerging data suggest they do not generate durable plasma cells, ...

A new approach has been proposed to suppress the side effects of messenger ribonucleic acid (mRNA), opening up possibilities ...

Ribosomes, the protein factories of the cell, are essential for all living organisms. They bind to mRNA and move along the ...

Victoria has strengthened its position as a global centre for mRNA innovation, with the backing a major expansion of BioNTech ...